These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis. Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110 [TBL] [Abstract][Full Text] [Related]
3. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry. Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957 [TBL] [Abstract][Full Text] [Related]
4. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276 [TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
6. Analysis of deaths in patients with an implantable cardioverter defibrillator. Edel TB; Maloney JD; Moore SL; McAllister H; Gohn D; Shewchik JM; Alexander L; Firstenberg MS; Castle LW; Simmons TW Pacing Clin Electrophysiol; 1992 Jan; 15(1):60-70. PubMed ID: 1371002 [TBL] [Abstract][Full Text] [Related]
7. Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rate. Kim SG; Fisher JD; Furman S; Gross J; Zilo P; Roth JA; Ferrick KJ; Brodman R J Am Coll Cardiol; 1991 Jun; 17(7):1587-92. PubMed ID: 2033191 [TBL] [Abstract][Full Text] [Related]
8. Survival in patients with depressed left ventricular function treated by implantable cardioverter defibrillator. Axtell K; Tchou P; Akhtar M Pacing Clin Electrophysiol; 1991 Feb; 14(2 Pt 2):291-6. PubMed ID: 1706840 [TBL] [Abstract][Full Text] [Related]
9. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm. Sueda S; Kohno H Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418 [TBL] [Abstract][Full Text] [Related]
10. Can we predict sudden cardiac death in long-term survivors of atrial switch surgery for transposition of the great arteries? Wheeler M; Grigg L; Zentner D Congenit Heart Dis; 2014; 9(4):326-32. PubMed ID: 24151816 [TBL] [Abstract][Full Text] [Related]
11. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study. Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY; Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651 [TBL] [Abstract][Full Text] [Related]
12. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy. Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S; J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347 [TBL] [Abstract][Full Text] [Related]
13. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies. Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327 [TBL] [Abstract][Full Text] [Related]
14. Long-term use of the wearable cardioverter defibrillator in patients with explanted ICD. Kaspar G; Sanam K; Gholkar G; Bianco NR; Szymkiewicz S; Shah D Int J Cardiol; 2018 Dec; 272():179-184. PubMed ID: 30121177 [TBL] [Abstract][Full Text] [Related]
16. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death. Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609 [TBL] [Abstract][Full Text] [Related]